
In an order communicated to the pharma giant, the ministry has said the company be made "liable" to pay adequate compensation to all patients who received articular surface replacement (ASR).
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2oPuFTL
via
IFTTT
0 comments:
Post a Comment